385 related articles for article (PubMed ID: 20628274)
1. Quality of life of survivors after pelvic exenteration for rectal cancer.
Austin KK; Young JM; Solomon MJ
Dis Colon Rectum; 2010 Aug; 53(8):1121-6. PubMed ID: 20628274
[TBL] [Abstract][Full Text] [Related]
2. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
[TBL] [Abstract][Full Text] [Related]
4. Quality of life after pelvic exenteration.
Roos EJ; de Graeff A; van Eijkeren MA; Boon TA; Heintz AP
Gynecol Oncol; 2004 Jun; 93(3):610-4. PubMed ID: 15196852
[TBL] [Abstract][Full Text] [Related]
5. Quality of life after total mesorectal excision for rectal cancer.
Gosselink MP; Busschbach JJ; Dijkhuis CM; Stassen LP; Hop WC; Schouten WR
Colorectal Dis; 2006 Jan; 8(1):15-22. PubMed ID: 16519633
[TBL] [Abstract][Full Text] [Related]
6. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
[TBL] [Abstract][Full Text] [Related]
7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of quality of life and sexual functioning after laparoscopic total mesorectal excision.
Breukink SO; van der Zaag-Loonen HJ; Bouma EM; Pierie JP; Hoff C; Wiggers T; Meijerink WJ
Dis Colon Rectum; 2007 Feb; 50(2):147-55. PubMed ID: 17160572
[TBL] [Abstract][Full Text] [Related]
9. Quality of life after low anterior resection and temporary loop ileostomy.
Tsunoda A; Tsunoda Y; Narita K; Watanabe M; Nakao K; Kusano M
Dis Colon Rectum; 2008 Feb; 51(2):218-22. PubMed ID: 18172730
[TBL] [Abstract][Full Text] [Related]
10. Surgery for locally recurrent rectal cancer.
Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
[TBL] [Abstract][Full Text] [Related]
11. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
12. Posterior pelvic exenteration for primary rectal cancer.
Bannura GC; Barrera AE; Cumsille MA; Contreras JP; Melo CL; Soto DC; Mansilla JE
Colorectal Dis; 2006 May; 8(4):309-13. PubMed ID: 16630235
[TBL] [Abstract][Full Text] [Related]
13. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
[TBL] [Abstract][Full Text] [Related]
15. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
[TBL] [Abstract][Full Text] [Related]
16. Long-term quality of life and sexual and urinary function after abdominoperineal resection for distal rectal cancer.
Kasparek MS; Hassan I; Cima RR; Larson DR; Gullerud RE; Wolff BG
Dis Colon Rectum; 2012 Feb; 55(2):147-54. PubMed ID: 22228157
[TBL] [Abstract][Full Text] [Related]
17. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery.
Pucciarelli S; Del Bianco P; Toppan P; Serpentini S; Efficace F; Pasetto LM; Friso ML; De Salvo GL; Nitti D
Ann Surg Oncol; 2008 Jul; 15(7):1846-54. PubMed ID: 18459006
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy.
Young JM; Badgery-Parker T; Masya LM; King M; Koh C; Lynch AC; Heriot AG; Solomon MJ
Br J Surg; 2014 Feb; 101(3):277-87. PubMed ID: 24420909
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenteration: a treatment for failed rectal cancer surgery.
Estes NC; Thomas JH; Jewell WR; Beggs D; Hardin CA
Am Surg; 1993 Jul; 59(7):420-2. PubMed ID: 8323074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
